This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Techne (TECH) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Techne (TECH) delivered earnings and revenue surprises of -6.82% and 4.44%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Techne (TECH) Q1 Earnings Expected to Decline
by Zacks Equity Research
Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXEL vs. TECH: Which Stock Is the Better Value Option?
by Zacks Equity Research
EXEL vs. TECH: Which Stock Is the Better Value Option?
New Strong Sell Stocks for October 3rd
by Zacks Equity Research
AFCG, AINC and TECH have been added to the Zacks Rank #5 (Strong Sell) List on October 3, 2023.
New Strong Sell Stocks for September 11th
by Zacks Equity Research
AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.
New Strong Sell Stocks for August 22nd
by Zacks Equity Research
AVTR, BHLB and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2023.
Techne (TECH) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Techne (TECH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Techne (TECH) Meets Q4 Earnings Estimates
by Zacks Equity Research
Techne (TECH) delivered earnings and revenue surprises of 0% and 1.11%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
GSK or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GSK vs. TECH: Which Stock Is the Better Value Option?
GSK vs. TECH: Which Stock Is the Better Value Option?
by Zacks Equity Research
GSK vs. TECH: Which Stock Is the Better Value Option?
GSK vs. TECH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
GSK vs. TECH: Which Stock Is the Better Value Option?
PBYI or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PBYI vs. TECH: Which Stock Is the Better Value Option?
PBYI vs. TECH: Which Stock Is the Better Value Option?
by Zacks Equity Research
PBYI vs. TECH: Which Stock Is the Better Value Option?
Here's What Key Metrics Tell Us About Techne (TECH) Q3 Earnings
by Zacks Equity Research
The headline numbers for Techne (TECH) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Techne (TECH) Meets Q3 Earnings Estimates
by Zacks Equity Research
Techne (TECH) delivered earnings and revenue surprises of 0% and 0.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
GSK or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GSK vs. TECH: Which Stock Is the Better Value Option?
Techne (TECH) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Techne (TECH) delivered earnings and revenue surprises of -4.08% and 6.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
REGN or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
REGN vs. TECH: Which Stock Is the Better Value Option?
Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VBK
GSK or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GSK vs. TECH: Which Stock Is the Better Value Option?
BIIB vs. TECH: Which Stock Is the Better Value Option?
by Zacks Equity Research
BIIB vs. TECH: Which Stock Is the Better Value Option?
VRTX or TECH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
VRTX vs. TECH: Which Stock Is the Better Value Option?